---
figid: PMC6678480__cells-08-00739-sch001
figtitle: Mechanism by which alantolactone (Ala) suppresses neuroinflammation
organisms:
- Armoracia rusticana
- Raphanus sativus
- Ligusticum sinense
- Inula helenium
- Saussurea costus
- Elephantopus scaber
- Escherichia coli
- Escherichia coli IS1
- Escherichia coli O111B4
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Oryctolagus cuniculus
- Homo sapiens
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC6678480
filename: cells-08-00739-sch001.jpg
figlink: /pmc/articles/PMC6678480/figure/cells-08-00739-sch001/
number: F1
caption: The mechanism by which alantolactone (Ala) suppresses neuroinflammation.
  Lipopolysaccharide (LPS) activates a classical inflammatory pathway in microglia
  by inducing the mitogen-activated protein kinase (MAPK) and nuclear factor kappa
  light-chain enhancer of activated B cells (NF-κB) signaling pathways. Ala inhibits
  the phosphorylation of c-Jun N-terminal kinases (JNKs) and extracellular signal-related
  kinases (ERKs) in the MAPK pathway and thus prevents the downstream protein AP-1
  from translocating to the nucleus. By inhibiting the degradation of IκBα, Ala also
  prevents p65 from translocating to the nucleus. Ultimately, this activity attenuates
  the expression of proinflammatory factors and prevents activated microglia from
  damaging neurons. In short, Ala could play a therapeutic role in neuroinflammation.
papertitle: Anti-Neuroinflammatory Effect of Alantolactone through the Suppression
  of the NF-κB and MAPK Signaling Pathways.
reftext: Liwei Tan, et al. Cells. 2019 Jul;8(7):739.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7119753
figid_alias: PMC6678480__F1
figtype: Figure
redirect_from: /figures/PMC6678480__F1
ndex: 46614568-df32-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6678480__cells-08-00739-sch001.html
  '@type': Dataset
  description: The mechanism by which alantolactone (Ala) suppresses neuroinflammation.
    Lipopolysaccharide (LPS) activates a classical inflammatory pathway in microglia
    by inducing the mitogen-activated protein kinase (MAPK) and nuclear factor kappa
    light-chain enhancer of activated B cells (NF-κB) signaling pathways. Ala inhibits
    the phosphorylation of c-Jun N-terminal kinases (JNKs) and extracellular signal-related
    kinases (ERKs) in the MAPK pathway and thus prevents the downstream protein AP-1
    from translocating to the nucleus. By inhibiting the degradation of IκBα, Ala
    also prevents p65 from translocating to the nucleus. Ultimately, this activity
    attenuates the expression of proinflammatory factors and prevents activated microglia
    from damaging neurons. In short, Ala could play a therapeutic role in neuroinflammation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IRF6
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - NFKBIA
  - EPHB2
  - MAPK3
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - SYT1
  - GORASP1
  - WNK1
  - Tlr4
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Ephb2
  - Mapk1
  - Nfkb1
  - Cdc37
  - Lsp1
  - Pold2
  - Cd40
  - Dctn2
  - Rela
  - Gorasp1
  - Ephb1
  - Syt1
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - Erk7
  - rl
  - Dif
  - dl
  - Rel
  - Hrb27C
  - betaTub60D
  - Rpt5
  - DCTN2-p50
  - wash
  - Alantolactone
  - LPS
---
